APA (7th ed.) Citation

Suzuki, S., Suzuki, K., Haruyama, Y., Fujita, H., Shiina, T., Kobayashi, S., . . . Hirata, K. (2025, June). A real-world study of the efficacy and tolerability of fremanezumab in migraine patients with a median follow-up of 14 months. Neurological Research and Practice.

Chicago Style (17th ed.) Citation

Suzuki, Shiho, Keisuke Suzuki, Yasuo Haruyama, Hiroaki Fujita, Tomohiko Shiina, Saro Kobayashi, Mukuto Shioda, Ryotaro Hida, and Koichi Hirata. "A Real-world Study of the Efficacy and Tolerability of Fremanezumab in Migraine Patients with a Median Follow-up of 14 months." Neurological Research and Practice Jun. 2025.

MLA (9th ed.) Citation

Suzuki, Shiho, et al. "A Real-world Study of the Efficacy and Tolerability of Fremanezumab in Migraine Patients with a Median Follow-up of 14 months." Neurological Research and Practice, Jun. 2025.